2018
DOI: 10.1038/s41598-018-25768-z
|View full text |Cite
|
Sign up to set email alerts
|

MiR-23a transcriptional activated by Runx2 increases metastatic potential of mouse hepatoma cell via directly targeting Mgat3

Abstract: MicroRNAs (miRNAs) and aberrant glycosylation both play important roles in tumor metastasis. In this study, the role of miR-23a in N-glycosylation and the metastasis of mouse hepatocellular carcinoma (HCC) cells was investigated. The miRNA expression array profiles that were confirmed by qPCR and Western blot analyses revealed higher miR-23a expression levels in Hca-P cells (with lymphatic metastasis potential) than in Hepa1–6 cells (with no lymphatic metastasis potential), while the expression of mannoside ac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
19
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 35 publications
(20 citation statements)
references
References 40 publications
(52 reference statements)
1
19
0
Order By: Relevance
“…Total protein extracts and western blot procedures were carried out as previously described 25 . Antibodies specific for the following targets were used: HNF4A (Abcam, USA); Sp1, c-Myc, and CREB (Cell Signaling Technology, USA); p-HNF4A (Ser313), p-Sp1 (1:500, Thr739), p-c-Myc (Ser62), p-CREB (Ser133), p-JNK (Thr183+Tyr185), and p-p38 (Tyr323) (Biosynthesis Biotechnology, Beijing, China); extracellular signal–regulated kinase (ERK; Proteintech, Wuhan, China); p-ERK (Thr202+Tyr204, Bioworld, Nanjing, China); and c-Jun N-terminal kinase (JNK), p38, and GAPDH (Proteintech, Wuhan, China).…”
Section: Methodsmentioning
confidence: 99%
“…Total protein extracts and western blot procedures were carried out as previously described 25 . Antibodies specific for the following targets were used: HNF4A (Abcam, USA); Sp1, c-Myc, and CREB (Cell Signaling Technology, USA); p-HNF4A (Ser313), p-Sp1 (1:500, Thr739), p-c-Myc (Ser62), p-CREB (Ser133), p-JNK (Thr183+Tyr185), and p-p38 (Tyr323) (Biosynthesis Biotechnology, Beijing, China); extracellular signal–regulated kinase (ERK; Proteintech, Wuhan, China); p-ERK (Thr202+Tyr204, Bioworld, Nanjing, China); and c-Jun N-terminal kinase (JNK), p38, and GAPDH (Proteintech, Wuhan, China).…”
Section: Methodsmentioning
confidence: 99%
“…The reverse transcription experiment followed the procedure of PrimeScript™ RT Reagent Kit (TaKaRa, Japan). qPCR was carried out as previously described (Huang et al, 2018). The upstream and downstream primers sequences for Cav‐1, Fut8, β‐catenin, Gapdh , and β‐actin are shown in Table 1.…”
Section: Methodsmentioning
confidence: 99%
“…Total protein extracts, western blot and lectin blot were performed as previously described (Huang et al, 2018). The following antibodies and lectins were obtained: anti‐GAPDH, anti‐phosphorylated retinoblastoma protein (p‐Rb), anti‐Cyclin D1, anti‐CDK1, anti‐Cyclin E2, anti‐p57, anti‐p27, anti‐Cyclin A1/2, Cullin antibodies from CST, anti‐Notch1, Hes‐related with YRPW motif (Hey1), hairy/enhancer‐of‐split (Hes1) antibodies from Proteintech, biotinylated Vicia villosa lectin (VVL) from Vector Laboratories, respectively.…”
Section: Methodsmentioning
confidence: 99%